Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

Ania M Owsianka, Alexander W Tarr, Zhen-yong Keck, Ta-Kai Li, Jeroen Witteveldt, Richard Adair, S.K.H Foung, Jonathan K. Ball, Arvind H Patel

Research output: Contribution to journalArticlepeer-review

Abstract

The humoral response to hepatitis C virus (HCV) may contribute to controlling infection. We previously isolated human monoclonal antibodies to conformational epitopes on the HCV E2 glycoprotein. Here, we report on their ability to inhibit infection by retroviral pseudoparticles incorporating a panel of full-length E1E2 clones representing the full spectrum of genotypes 1-6. We identified one antibody, CBH-5, that was capable of neutralizing every genotype tested. It also potently inhibited chimeric cell culture-infectious HCV, which had genotype 2b envelope proteins in a genotype 2a (JFH-1) background. Analysis using a panel of alanine-substitution mutants of HCV E2 revealed that the epitope of CBH-5 includes amino acid residues that are required for binding of E2 to CD81, a cellular receptor essential for virus entry. This suggests that CBH-5 inhibits HCV infection by competing directly with CD81 for a binding site on E2.
Original languageEnglish
Article number3
Pages (from-to)653-9
Number of pages7
JournalJournal of General Virology
Volume89
DOIs
Publication statusPublished - Mar 2008

Keywords

  • Antibodies, Monoclonal/immunology
  • Antigens, CD
  • Antigens, CD81
  • Cell Line
  • Epitopes
  • Genotype
  • Hepacivirus
  • Hepatitis C Antibodies/immunology
  • Humans
  • Neutralization Tests
  • Retroviridae/genetics
  • Retroviridae/immunology
  • Viral Envelope Proteins
  • Virion

Fingerprint

Dive into the research topics of 'Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein'. Together they form a unique fingerprint.

Cite this